Walter A. Hall, MD, MBA


Professor
Department of Neurosurgery
SUNY Upstate Medical University
750 East Adams Street
Syracuse, NY 13210, USA

Biography

Dr. Hall is a Professor of Neurosurgery at the State University of New York Upstate Medical University in Syracuse, New York. Prior to his arrival in Syracuse in 2007, he was a Professor of Neurosurgery, Radiation Oncology, and Radiology at the University of Minnesota School of Medicine and the Shelly N. and Jolene J. Chou Chair in Neurosurgery. Dr. Hall received his BA degree from Columbia College of Columbia University in 1979 and his MD degree from the College of Physicians and Surgeons of Columbia University in 1983. He completed his General Surgery Internship at the University of Pittsburgh in 1984 and his neurosurgical residency was completed at the University of Pittsburgh in 1990. During his training, he spent two years at the National Institutes of Health in the Surgical Neurology Branch as a Medical Staff Fellow from 1987 to 1989. He was the 1990 recipient of the Van Wagenen Fellowship of the American Association of Neurological Surgeons which he spent working in the Department of Tumor Biology of the Norwegian Radium Hospital in Oslo, Norway. Dr. Hall joined the faculty of the University Of Minnesota School of Medicine in February 1991. In 1996 he was awarded the Mahaley Clinical Research Award in brain tumors by the Joint Section of Tumors of the Congress of Neurological Surgeons and the American Association of Neurological Surgeons. In 1998, Dr. Hall received his MBA degree from the Carlson School of Management of the University of Minnesota. He was the Director of the Brain Tumor Center of Minnesota and has extensive clinical and laboratory experience in developing new therapeutic modalities for treating brain tumors. Treatment modalities for brain tumors that have been developed under Dr. Halls guidance include stereotactic radiosurgery, fractionated stereotactic radiotherapy, blood-brain barrier disruption chemotherapy, interventional magnetic resonance imaging-guided neurosurgery, and targeted toxin therapy. He performed more that 1,000 neurosurgical procedures using intraoperative magnetic resonance imaging guidance over from 1997 to 2007. In addition, Dr. Hall has authored more than 180 publications on brain tumors, targeted toxins, intraoperative magnetic resonance imaging-guided neurosurgery, and central nervous system infections.

Research Interest

His research interests include: Central Nervous System Infections, Neuro-Oncology, Intraoperative MRI, Targeted Toxins, Brain Tumors, Neurosurgery.

Scientific Activities

AWARDS

• (1975) Senior Scholar-Athlete Award of St. Stephens School, Alexandria, Virginia
• (1978) Phi Gamma Delta Educational Foundation Award, New York, New York
• (1989) Southern Medical Association Section on Neurosurgery Physician-in-Training Award
• (1990) Van Wagenen Fellowship Norwegian Radium Hospital, Oslo, Norway Frenchay Hospital, Bristol, United Kingdom
• (1991) American College of Surgeons Fellowship second alternate
• (1994) Preuss Award for Resident Brain Tumor Research (Eric P. Flores, M. D.)
• (1994) State of Minnesota Outstanding Physician under 40 years of age
• (1996) Preuss Award for Resident Brain Tumor Research (Margaret A. Wallenfriedman, M. D.)
• (1996) Mahaley Clinical Award from the Joint Section on Tumors of the Congress of Neurological Surgeons and the American Association of Neurological Surgeons
• (1997) Preuss Award for Resident Brain Tumor Research (Walter C. Jean, M. D.)
• (2000) Minneapolis/St. Paul Magazine “Top Doctor” for Neurosurgery
• (2002) Minneapolis/St. Paul Magazine “Top Doctor” for Neurosurgery
• (2004) Consumers CHECKBOOK Guide to Top Doctors (Minneapolis)
• (2005) Consumers CHECKBOOK Guide to Top Doctors (Minneapolis)
• (2006-2007) Shelly N. and Jolene J. Chou Chair in Neurosurgery, University of Minnesota
• (2007-2011) Robert B. and Molly G. King Chair in Neurosurgery, SUNY Upstate Medical University
• (2007) ISMRM and ESMRMB Joint Annual Meeting Outstanding Teacher Award in Cross- discipline clinical categorical courses
• (2009) “The Best Doctors in America” induction
• (2009) Central New York Magazine “Top Doctor” for Neurosurgery
• (2012) Patients Choice Award

ACADEMIC APPOINTMENTS

• (1985) Visiting Fellow in Neurology, The Neurological Institute, New York, New York
• (1986) Clinical Instructor in Neuropathology, University of Pittsburgh School of Medicine, • Pittsburgh, Pennsylvania
• (1986) Neurosurgeon, University of Pittsburgh Football Team, Pittsburgh, Pennsylvania
• (1987) Clinical Instructor in the Trauma Nurse Course, Childrens Hospital of Pittsburgh, Pittsburgh, Pennsylvania
• (1987-1989) Medical Staff Fellow, Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland
• (1990-1995) Assistant Professor of Neurosurgery, University of Minnesota School of Medicine, Minneapolis, Minnesota
• (1994-1995) Assistant Professor of Radiation Oncology, University of Minnesota School of Medicine, Minneapolis, Minnesota
• (1995-1999) Associate Professor of Neurosurgery, University of Minnesota School of Medicine, Minneapolis, Minnesota
• (1995-1999) Associate Professor of Radiation Oncology, University of Minnesota School of Medicine, Minneapolis, Minnesota
• (1998-1999) Associate Professor of Radiology, University of Minnesota School of Medicine, Minneapolis, Minnesota
• (1999-2007) Professor of Neurosurgery, University of Minnesota School of Medicine, Minneapolis, Minnesota
• (1999-2007) Professor of Radiation Oncology, University of Minnesota School of Medicine, Minneapolis, Minnesota
• (1999-2007) Professor of Radiology, University of Minnesota School of Medicine, Minneapolis, Minnesota
• (2003-2007) Member of the Graduate Faculty in the Field of Biophysical Sciences and Medical Physics
• (04/07-08/09) Chairman, Department of Neurosurgery, State University of New York (SUNY) Upstate Medical University, Syracuse, New York
• (04/07-08/11) Program Director, Department of Neurosurgery, State University of New York (SUNY) Upstate Medical University, Syracuse, New York
• (2007-Present) Professor of Neurosurgery, State University of New York (SUNY) Upstate Medical University, Syracuse, New York

University of Minnesota Activities

• (1991) Medical Record and Patient Care Information Committee
• (1991) Biomedical Ethics Education Subcommittee
• (1992) Clinical Outcomes Task Force Subcommittee
• (1992) Surgical Specialties Course Director
• (1996) Years 3 & 4 Externship Director
• (1998) Member, Curriculum Council
• (1993) Untenured Faculty Advisory Committee
• (1993) Program Development Committee
• (1995) Chairman, Neuroscience Subcommittee
• (1993) Associate Member of the Graduate Faculty
• (1993) Director of Graduate Studies
• (1993) Emerging Technology Task Force
• (1993) Health Sciences Policy and Review Council Program Review Subcommittee
• (1993) Departmental Education Liaison for Curriculum
• (1994) Advisory Search Committee for Cancer Center Director
• (1994) Director of Quality Assurance in Neurosurgery
• (1994) Cancer Center Tumor Bank Committee
• (1996) Executive Committee Cancer Center Tumor Bank
• (1995) Professional Services Committee
• (1996) Director of Graduate Medical Education for Neurosurgery
• (1997) Graduate Medical Education Committee
• (1997) University of Minnesota Physicians Compensation, Benefits and Human Resources Committee
• (1997) University of Minnesota Physicians Clinical Services and Quality Assurance Committee
• (1997) Medical Director for Clinical Integration of Neurosciences
• (1997) Member, Institutional Review Board: Human Subjects Committee
• (1997) University of Minnesota Physicians Finance Council
• (1997) Chairman, Neuroscience Quality Improvement Committee
• (1998) Chairman, University of Minnesota Physicians Program Development Committee
• (1998) University of Minnesota Physicians Oncology Service Task Force
• (1998-2004) Member, Curriculum Committee
• (1998) Council of Clinical Sciences GME Subcommittee
• (1998) Chairman, Fairview-AHC Access Pathways Review Committee
• (1998) Member, Search Committee for Neuropathology
• (1998) Member, Search Committee for Chairman of Therapeutic Radiology
• (1998) Member, Consultation Process Advisory Committee
• (1999-2003) Alternate Member, Promotions and Tenure Committee of the Medical School
• (1999) Member, Search Committee for Chairman of Neurology
• (1999-2004) Years 3 and 4 Neurosurgery Course Director
• (1999) Chairman, Grade Inflation Subcommittee
• (2000) Clinical Sciences Committee for AHC Planning
• (2000) Co-Director, Fairview-University Brain Tumor Center
• (2000) Member, University of Minnesota Physicians Human Resources Committee
• (2000) Member, University of Minnesota Physicians Clinical Services & Program Development Committee
• (2000) Medical/Surgical Collaborative Practice Committee
• (2000-2006) Member, University of Minnesota Physicians Board of Directors
• (2000) Member, Search Committee for Endowed Chair in Pediatric Brain Tumors
• (2001) Member, Search Committee for Neuropathology
• (2001) Member, University of Minnesota Physicians Compliance and Clinical Practice Committee
• (2001) Member, University of Minnesota Physicians Risk Management Subcommittee
• (2001) Member, Medical School Years 3 and 4 Transition Course Committee
• (2001) Member, University of Minnesota Physicians Nominating Committee
• (2001) UM Physicians Compliance Leader, Department of Neurosurgery
• (2002-2004) Co-chair, Neuroscience Clinical Program, University of Minnesota Physicians
• (2002-2004) Member, Council of Clinical Program Leaders, University of Minnesota Physicians
• (2002) Member, Technology Assessment Committee
• (2003) Chair, University of Minnesota Physicians Human Resources Committee
• (2003) Member, University of Minnesota Physicians Compensation Committee
• (2003) Member, Peer Review Subcommittee of the University of Minnesota Physicians Compliance Committee
• (2003) Member, University of Minnesota Physicians Interdisciplinary Program Development Committee
• (2003) Member, University of Minnesota Physicians Investment Committee
• (2003) Member, University of Minnesota Physicians Committee on Committees
• (2004) Member, Faculty Advisory Council
• (2005-2006) Chief of Clinical Service (Neurosurgery)
• (2005-2006) Executive Committee of the Medical Staff of Fairview-University Medical Center
• (2005) Co-Director, Gamma Knife Center
• (2005) Chair, Institutional Review Board 02 Committee
• (2005) Member, Institutional Review Board Executive Committee
• (2006) Member, University of Minnesota Cancer Center Oncology Council
• (2006) Member, Search Committee for Neuroscience Administrative Center Director
• (2006) Department of Neurosurgery Associate Department Head for Academic Affairs
• (2006) Chair, University of Minnesota Physicians Investment Committee
• (2006) Alternate Reviewer, UMMC Medical Staff Credentialing Committee

SUNY UPSTATE MEDICAL UNIVERSITY ACTIVITIES

• (2007-2009) College of Medicine Executive Committee
• (2007-2009) University Hospital Governance Committee
• (2007-2009) Operative Services Planning Committee
• (2007-2009) Strategic Planning Committee
• (2007-2009) University Medical Associates at Syracuse, Inc. Governing Board
• (2007-2009) Vertical Expansion Steering Committee
• (2007-2009) Neuroscience Quality Team Committee
• (2007-2009) Institute for Human Performance Magnetic Resonance Imaging Core Advisory Committee
• (2007-2009) Stroke Center Committee
• (2007-2009) Intensive Care Unit Governance Committee

MEMBERSHIP IN PROFESSIONAL AND SCIENTIFIC SOCIETIES

•(1979) Senior Society of Nacoms of Columbia College
•(1980) Alumni Secondary Schools Committee of Columbia College
•(1990) Stuart Rowe Society of the University of Pittsburgh Department of Neurosurgery
•(1991) Peyton Society of the University of Minnesota Department of Neurosurgery
•(1991) American Medical Association
•(1991) Minnesota Medical Association
•(1991) Hennepin County Medical Society
•(1991) Minnesota Neurosurgical Society
•(2003) Treasurer
•(2004) President
•(1991) Neurosurgical Research Society
•(1991) Brain Tumor Cooperative Group
• Principal Investigator, University of Minnesota Hospital and Clinic •(1992) Congress of Neurological Surgeons (1992)
•(1992) Alternate Delegate to the Joint Council of State Neurosurgical Societies
•(1992) Member Open Scientific Session Committee
•(1992) Member Young Physicians Committee
•(1993-1994) Member Sergeant-At-Arms Committee
•(1993) Member General Scientific Session I Committee
•(1993) Member General Scientific Session IV Committee
•(1994) Chairman Poster Session Committee
•(1995) Chairman Host Committee
•(1992) Joint Section on Tumors
•(1995) Member Membership Committee (1995)
•(1996) Chairman General Scientific Session I Committee
•(1996) Co-chairman Sergeant-at-Arms Committee
•(1996) Member Scientific Program Committee Tumor Satellite Conference
•(2000) Joint Section on Stereotactic and Functional Neurosurgery
•(1992) American Association for Cancer Research
•(1992) International Stereotactic Radiosurgery Society
•(1993) Radiation Therapy Oncology Group
•(1993) Neurosurgery Subcommittee of the Surgical Committee
•(1994) American Association of Neurological Surgeons
•(1995) Fellow of the American College of Surgeons
•(1995) North American Society for Neuro-Oncology
•(1997-2001) American College of Physician Executives
•(1998) Society for Neuroscience
•(2000) American Society for Stereotactic and Functional Neurosurgery (2000)
•(2000) World Society for Stereotactic and Functional Neurosurgery
•(1998) Society for Neuro-Oncology
•(2000) Scientific Program Committee
•(2000) Future Sites Committee
•(2004) Chairman, Future Sites Committee
•(2004) Scientific Program Committee (2004)
•(2004) Board of Directors
•(2001) Neurosurgical Society of America
•(2005) Member, Nominating Committee
•(2005-2007) Van Wagenen Selection Committee of the American Association of Neurological Surgeons
•(2007) Van Wagenen Fellowship Committee of the American Association of Neurological Surgeons
•(2006-2007) Chairman, Van Wagenen Selection Committee of the American Association of Neurological Surgeons
•(2007) Society of Neurological Surgeons
•(2007) Onondaga County Medical Society
•(2007) Medical Society of the State of New York
•(2007-2009) New York State Neurosurgical Society
•(2008) Intraoperative Imaging Society
•(2008-2010) Board of Directors
•American Board of Neurological Surgery •(2008) Guest Oral Board Examiner
•(2009) American Radium Society

Publications

ARTICLES

1. Wise TN, Hall WA, Wong O. The relationship of cognitive styles and affective status to postoperative analgesic utilization. J Psychosom Res. 1978; 22: 513-519.
2. Wise TN, Hall WA, Wong O. A simple screening technique to estimate narcotic utilization. South Med J. 1979; 72: 415-417.
3. Wise TN, Hall WA, Wong O. Pain response compared: After back surgery, cholecystectomy. Va Med. 1981; 108: 183-185.
4. Hall WA, Yunis EJ, Albright AL. Anaplastic ganglioglioma in an infant: Case report and review of the literature. Neurosurgery. 1986; 19: 1016-1020.
5. Hall WA, Lunsford LD. Changing concepts in the treatment of colloid cysts: An eleven year experience in the computed tomography era. J Neurosurg. 1987; 66: 186-191.
6. Hall WA, Martinez AJ, Dummer JS, Lunsford LD. Nocardial brain abscess: Diagnostic and therapeutic use of stereotactic aspiration. Surg Neurol. 1987; 28: 114-118.
7. Martinez AJ, Pollack I, Hall WA, Lunsford LD. Touch preparations in the intraoperative diagnosis of central nervous system lesions: A comparison with frozen sections and paraffin-embedded sections. Modern Pathology. 1988; 1: 378-384.
8. Hall WA, Albright AL, Brunberg JA. Diagnosis of tethered cords by magnetic resonance imaging. Surg Neurol. 1988; 30: 60-64.
9. Hall WA, Martinez AJ, Dummer JS. Progressive multifocal leukoencephalopathy after cardiac transplantation. Neurology. 1988; 38: 995-996.
10. Hall WA, Martinez AJ, Dummer JS, et al. Central nervous system infections in heart and heart-lung transplant recipients. Arch Neurol. 1989; 46: 173-177.
11. Hall WA, Oldfield EH, Doppman JL. Recanalization of spinal arteriovenous malformations following embolization. J Neurosurg. 1989; 70: 714-720.
12. Hall WA, Merrill MJ, Youle RJ. Growth factor receptors on brain tumors. Surgical Forum. 1989; 40: 498-500.
13. Hall WA, Martinez AJ. Neuropathology of pediatric liver transplantation. Ped Neurosci. 1989; 15: 269-275.
14. Pollack IF, Pang D, Hall WA. Subarachnoid-pleuromediastinal fistula. Neurosurgery. 1990; 26: 519-525.
15. Hall WA, Merrill MJ, Walbridge S, Youle RJ. Epidermal growth factor receptors on ependymomas and other brain tumors. J Neurosurg. 1990; 72: 641-646.
16. Horowitz MJ, Hall WA. Central nervous system germinomas: A review. Arch Neurol. 1991; 48: 652-657. doi: 10.1001/archneur.1991.00530180110026
17. Hall WA, Fodstad Ø. Immunotoxins and central nervous system neoplasia. J Neurosurg. 1992; 76: 1-12.
18. Wen DY, Bottini AJ, Hall WA, Haines SJ. The intraventricular use of antibiotics. Neurosurg Clin N Am. 1992; 3: 343-354.
19. Hall WA. Neurosurgical infections in the compromised host. Neurosurg Clin N Am. 1992; 3: 435-442.
20. Hall WA, Godal A, Juell S, Fodstad Ø. In vitro efficacy of transferrin-toxin conjugates against glioblastoma multiforme. J Neurosurg. 1992; 76: 838-844. doi: 10.3171/jns.1992.76.5.0838
21. Wen DY, Hall WA, Godal A, Fodstad Ø. Rapid transferrin receptor determination on human brain tumors. Surgical Forum. 1992; 43: 526-528.
22. Nida TY, Hall WA, Glantz MJ, Clark HB. Metastatic carcinoid tumor to orbit and brain. Neurosurgery. 1992; 31: 949-952.
23. Hall WA. Neurosurgical infections in the compromised host. Neurosurgical Consultations. 1992; 3: 25.
24. Wen DY, Hall WA, Miller DA, Seljeskog EL, Maxwell RE. Targeted brain biopsy: A comparison of freehand computed tomography-guided and stereotactic techniques. Neurosurgery. 1993; 32: 407-413.
25. Sung C, Dedrick RL, Hall WA, Johnson PA, Youle RJ. The spatial distribution of immunotoxins in solid tumors: Assessment by quantitative autoradiography. Cancer Res. 1993; 53: 2092-2099.
26. Hall WA. Infectious lesions of the brain stem. Neurosurg Clin N Am. 1993; 4: 543-551.
27. Hall WA. Central nervous system germinomas. Neurosurgical Consultations. 1993; 4: 15.
28. Wen DY, Hall WA, Fodstad Ø. Rapid detection of transferrin receptor expression on glioma cell lines using magnetic microspheres. Neurosurgery. 1993; 33: 878-881.
29. Madison MT, Hall WA, Latchaw RE, Loes DJ. Radiologic diagnosis, staging, and follow-up of adult central nervous system primary malignant glioma. Radiologic Clin N Am. 1994; 32: 183-196.
30. Nussbaum ES, Hall WA. Rhinocerebral mucormycosis: Changing patterns of disease. Surg Neurol. 1994; 41: 152-156.
31. Hall WA, Myklebust A, Godal A, Nesland JM, Fodstad Ø. In vivo efficacy of intrathecal transferrin-Pseudomonas exotoxin A immunotoxin against LOX melanoma. Neurosurgery. 1994; 34: 649-656. doi: 10.1097/00006123-199404000-00012
32. Hall WA, Luciano MG, Doppman JL, Patronas NJ, Oldfield EH. Pituitary magnetic resonance imaging in normal human volunteers: Occult adenomas in the general population. Ann Intern Med. 1994; 120: 817-820.
33. Hall WA. Hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease) presenting with polymicrobial brain abscess. J Neurosurg. 1994; 81: 294-296.
34. Weprin BP, Hall WA, Bergman TA. Central neurocytoma: Diagnosis and treatment. Minnesota Medicine. 1994; 77: 43-46.
35. Myklebust AT, Helseth A, Hall WA, Breistøl K, Fodstad Ø. Nude rat models for human tumor metastasis to CNS. Procedures for intracarotid delivery of cancer cells and drugs. J Neuroonc. 1994; 21: 215-224.
36. Wen DY, Hall WA, Conrad J, Godal A, Flørenes VA, Fodstad Ø. In vitro and in vivo variation in transferrin receptor expression on a human medulloblastoma cell line. Neurosurgery. 1995; 36: 1158-1164.
37. Chiang L, Flores EP, Wen DY, Hall WA, Low WC. Gene therapy for neurodegenerative disorders and malignant brain tumors. Behavioral and Brain Sciences. 1995; 18: 52-53.
38. Glantz MJ, Hall WA, Cole BF, et al. Diagnosis, management, and survival of patients with leptomeningeal cancer and cerebrospinal fluid flow abnormalities. Cancer. 1995; 75: 2919-2931.
39. Hall WA, Djalilian HR, Sperduto PW, et al. Stereotactic radiosurgery for recurrent malignant gliomas. J Clin Oncol. 1995; 13: 1642-1648.
40. Gerbi BJ, Roback DM, Humphrey SD, Hall WA. Maintaining accuracy in stereotactic radiosurgery. Int J Rad Oncol Biol Phys. 1995; 32: 1199-1203.
41. Hall WA, Clark HB. Sacrococcygeal cordoma metastatic to the brain with review of the literature. J Neurooncol. 1995:25: 155-159.
42. Latchaw RE, Hu X, Ugurbil K, Hall WA, Madison MT, Heros RC. Functional magnetic resonance imaging as a management tool for cerebral arteriovenous malformations. Neurosurgery. 1995; 37: 619-626.
43. Peterson K, Clark HB, Hall WA, Truwit CL. Multifocal enhancing magnetic resonance imaging lesions following cranial irradiation. Ann Neurol. 1995; 38: 237-244.
44. Hall WA, Flores EP, Low WC. Antisense oligonucleotides for central nervous system tumors. Neurosurgery. 1996; 38: 376-383.
45. Hall WA. Immunotoxin therapy. Neurosurg Clin N Am. 1996; 7: 537-546.
46. Nussbaum ES, Djalilian HR, Cho KH, Hall WA. Brain metastases: Histology, multiplicity, surgery and survival. Cancer. 1996; 78: 1781-1788.
47. Sperduto PW, Hall WA. Radiosurgery, cost-effectiveness, gold standards, the scientific method, cavalier cowboys and the cost of hope. Int J Rad Oncol Biol Phys. 1996; 36: 511- 513.
48. Weprin BP, Hall WA, Cho KH, Sperduto PW, Gerbi BJ, Moertel C. Stereotactic radiosurgery in pediatric patients. Pediatr Neurol. 1996; 15: 193-199.
49. Eriksen SK, Hall WA. Chemotherapy delivered with blood-brain barrier disruption offers new option for treating malignant brain tumors. Cope. 1996; 38-39.
50. Nussbaum ES, Hall WA. Rapid diagnosis of intracranial fungal infections: Technical note. Chula Med J. 1996; 40: 255-258.
51. Hall WA. Stereotactic radiosurgery for brain metastases. Crit Rev Neurosurg. 1996; 6: 257-262.
52. Galicich W, Hall WA, Cho KH. The use of stereotactic radiosurgery to treat neurological tumors. Minnesota Medicine. 1997; 80: 18-22.
53. Djalilian HR, Hall WA. Malignant gliomas of the cerebellum: An analytic review. J Neuroonc. 1998; 36: 247-257.
54. Weprin BP, Hall WA, Goodman J, Adams GS. Long term survival in rhinocerebral mucormycosis: A case report. J Neurosurg. 1998; 88: 570-575.
55. Jean WC, Spellman SR, Wallenfriedman MA, Hall WA, Low WC. Interleukin-12 based immunotherapy against peripheral and central nervous system 9L glioma. Neurosurgery. 1998; 42: 850-857.
56. Hall WA. The safety and efficacy of stereotactic biopsy for intracranial lesions. Cancer. 1998; 82: 1749-1755.
57. Jean WC, Hall WA. Management of cranial and spinal infections. Contemporary Neurosurgery. 1998; 20(9): 1-10.
58. Cho KH, Hall WA, Lee AK, et al. Stereotactic radiosurgery for patients with single brain metastasis. J Radiosurgery . 1998; 1: 79-85.
59. Martin AJ, van Vaals JJ, Hall WA, Liu H, Truwit CL. Intra-operative MR monitored neurosurgery. Medica Mundi. 1998; 42: 12-21.
60. Cho KH, Hall WA, Gerbi BJ, Higgins PD, Bohen M, Clark HB. Selection criteria for the treatment of brain metastases with stereotactic radiosurgery. J Neuroonc. 1998; 40: 73-86.
61. Maurer CR Jr, Hill DLG, Martin AJ, et al. Measurement of intraoperative brain deformation using a 1.5 tesla interventional MR system: Preliminary results. IEEE Transactions on Medical Imaging. 1998; 17: 817-825.
62. Wen DYK, Hall WA. Complications of subcutaneous low-dose dose heparin therapy in neurosurgical patients. Surgical Neurol. 1998; 50: 521-525.
63. Hall WA, Martin AJ, Liu H, et al. High-field strength interventional MR imaging for pediatric neurosurgery. Pediatric Neurosurgery. 1998; 29: 253-259. doi: 10.1159/000028732
64. Hall WA, Martin AJ, Liu H, Nussbaum ES, Maxwell RE, Truwit CL. Brain biopsy using high-field strength interventional MR imaging. Neurosurgery. 1999; 44: 807-814.
65. Wallenfriedman MA, Conrad JA, Hall WA, et al. Effects of localized infusion of granulocyte-macrophage colony stimulating factor and inoculations of irradiated glioma cells on tumor regression. J Neurosurg. 1999; 90: 1064-1071.
66. Djalilian HR, Shah MV, Hall WA. Radiographic incidence of multicentric malignant gliomas. Surg Neurol. 1999; 51: 554-558.
67. Gerbi BJ, Lewandowski LA, Higgins PD, et al. Stereotactic radiosurgery for treatment of subfoveal choroidal neovascularization in age- related macular degeneration. J Radiosurgery. 1999; 2: 113-118.
68. Cho KH, Hall WA, Gerbi BJ, Higgins PD, McGuire WA, Clark HB. Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas. Int J Rad Oncol Biol Phys. 1999; 45: 1133-1141.
69. Hall WA, Liu H, Martin AJ, Truwit CL. Comparison of stereotactic brain biopsy to interventional MRI-guided brain biopsy. Stereotact Funct Neurosurg. 1999; 73:148-153.
70. Doolittle ND, Miner M, Hall WA, et al. Safety and efficacy of a multi- center study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of malignant brain tumors. Cancer. 2000; 88: 637-47.
71. Hall WA, Liu H, Truwit CL. Navigus trajectory guide. Neurosurgery. 2000; 46: 502-504.
72. Hall WA. Targeted toxin therapy for malignant astrocytoma. Neurosurgery. 2000; 46: 544- 552.
73. Hall WA, Liu H, Martin AJ, Pozza CH, Maxwell RE, Truwit CL. Safety, efficacy, and functionality of high-field strength interventional magnetic resonance imaging for neurosurgery. Neurosurgery. 2000; 46: 632-642.
74. Martin AJ, Hall WA, Liu H, Pozza CH, Maxwell RE, Truwit CL. Intraoperative monitoring of brain tumor resection with high-field interventional MR: Initial results. Radiology. 2000; 215: 221-228.
75. Hall WA, Djalilian HR, Nussbaum ES, Cho KH. Long-term survival with metastatic cancer to the brain. Medical Oncology. 2000; 17: 1-8.
76. Cho KH, Hall WA, Gerbi BJ, Higgins PD. The role of radiosurgery for multiple brain metastases. Neurosurg Focus. 2000; 2(2).
77. Hall WA. Targeted Toxin Therapy for Brain Tumors. Minnesota Physician. 2000; 14: 32-34.
78. Liu H, Hall WA, Martin AJ, Maxwell RE, Truwit CL. MR-guided and MR-monitored neurosurgical procedures at 1.5 T. J Comput Assist Tomogr. 2000; 24: 909-918.
79. Kim K-U, Ni HT, Cho KH, Low WC, Vallera DA, Hall WA. In vitro efficacy of recombinant diphtheria toxin-murine interleukin-4 conjugate (DT390-mIL4) on mouse glioblastoma and neuroblastoma cell lines and its additive effect with irradiation. Neurosurg Focus. 2000; 6(5).
80. Hall WA. High-field MRI in intracranial interventions. Medica Mundi. 2000; 44: 10-15.
81. Hill DLG, Hartkens T, Martin AJ, Hall WA, Liu H, Truwit CL. Measuring tissue deformation with interventional MR. Medica Mundi. 2000; 44: 16-19.
82. Kim KU, Ni HT, Low WC, Hall WA. Growth factor receptor expression on brain tumor cell lines: Preliminary study for in vitro and in vivo experiments of immunotoxin therapy. J Korean Neurosurg Soc. 2000; 29: 731-739.
83. Hall WA, Liu H, Martin AJ, Maxwell RE, Truwit CL. Brain biopsy using prospective stereotaxis and a trajectory guide. J Neurosurg. 2001; 91: 67-71.
84. Doolittle ND, Anderson CP, Hall WA, et al. Importance of dose-intensity in neuro-oncology clinical trials. Neuro-onc. 2001; 3: 46-54.
85. Hall WA, Martin AJ, Liu H, Truwit CL. Improving diagnostic yield in brain biopsy: Coupling spectroscopic targeting with real time needle placement. J Magn Reson Imaging. 2001; 13: 12-15. doi: 10.1002/1522-2586(200101)13:13.0.CO;2-Q
86. Liu H, Hall WA, Martin AJ, Truwit CL. Biopsy needle tip artifact in MR-guided neurosurgery. J Magn Reson Imaging. 2001; 13: 16-22.
87. Martin AJ, Liu H, Hall WA, Truwit CL. Preliminary assessment of turbo spectroscopic imaging for targeting in brain biopsy. AJNR. 2001; 22: 959-968.
88. Ni H-T, Spellman SR, Jean WC, Wallenfriedman MA, Hall WA, Low WC. Immunization with dendritic cells pulsed with tumor extract increases survival of mice bearing intracranial gliomas. J Neuroonc. 2001; 51: 1-9.
89. Liu H, Hall WA, Martin AJ, Truwit CL. An efficient chemical shift imaging scheme for magnetic resonance-guided neurosurgery. J Magn Reson Imaging. 2001; 14: 1-7.
90. Lam CH, Hall WA, Truwit CL, Liu H. Intraoperative MRI-guided approaches to the pediatric posterior fossa tumors. Pediatric Neurosurgery. 2001; 34: 295-300.
91. Tummala RP, Chu RM, Hall WA. Focal intracranial infections due to Propionibacterium acnes: Report of three cases. Neurosurgery. 2001; 49: 717-720.
92. Hall WA, Liu H, Martin AJ, Truwit CL. Minimally invasive procedures: Interventional MR image-guided neurobiopsy. Neuroimaging Clin N Am. 2001; 11: 705-713.
93. Tummala RP, Chu RM, Liu H, Truwit CL, Hall WA. Optimizing brain tumor resection: High-field interventional MR imaging. Neuroimaging Clin N Am. 2001; 11: 673-683.
94. Truwit CL, Hall WA. Intraoperative MR systems: High field approaches. Neuroimaging Clin N Am. 2001; 11: 647-652.
95. Liu H, Hall WA, Truwit CL. Neuronavigation in interventional MR imaging: Prospective stereotaxy. Neuroimaging Clin N Am. 2001; 11: 697-706.
96. Kucharczyk J, Hall WA, Broaddus WC, Gillies GT, Truwit CL. Cost-efficacy of MR- guided neurointerventions. Neuroimaging Clin N Am. 2001; 11: 769-774.
97. Lo S, Cho KH, Hall WA, Hernandez WL, Lee CK, Clark HB. Does the extent of surgery have an impact on the survival of patients who receive postoperative radiation therapy for supratentorial low grade gliomas?. Int J Cancer. 2001; 96: 71-78.
98. Djalilian HR, Tekin M, Hall WA, Adams GL. Metastatic head and neck squamous cell carcinoma to the brain. Auris Nasus Larynx. 2002; 29: 47-54.
99. Hall WA, Martin AJ, Kowalik K, Liu H, Truwit CL, Kucharczyk J. Economic justification for MR-guided neurosurgery. Medica Mundi. 2002; 46: 72-78.
100. Doolittle ND, Abrey LE, Hall WA, et al. Targeted delivery in primary and metastatic brain tumors: Summary report of the seventh annual meeting of the blood-brain barrier disruption consortium. Clin Cancer Res. 2002; 8: 1702-1709.
101. Vallera DA, Li C, Jin N, Hall WA. Targeting overexpressed urokinase-type plasminogen activator receptor (uPAR) on human glioblastoma with the diphtheria toxin fusion DTAT in nude mice. J Natl Cancer Inst. 2002; 94: 597-606.
102. Li C, Hall WA, Jin N, Todhunter DA, Panoskaltsis-Mortari A, Vallera DA. Targeting glioblastoma multiforme with an IL-13/diphtheria toxin fusion protein in vitro and in vivo in nude mice. Protein Engineering. 2002; 15: 419-427.
103. Lo SS, Cho KH, Hall WA, et al. Single dose versus fractionated stereotactic radiotherapy for meningiomas. Can J Neurol Sci. 2002; 29: 240-248.
104. Hall WA, Liu H, Maxwell RE, Truwit CL. Influence of 1.5-tesla intraoperative MR imaging on surgical decision making. Acta Neurochir. 2002; 85: 29-37.
105. Liu H, Hall WA, Truwit CL. The roles of functional MRI in MR-guided neurosurgery in a combined 1.5 tesla MR-operating room. Acta Neurochir. 2002; 85: 127-135.
106. Hall WA, Kowalik K, Liu H, Truwit CL, Kucharczyk J. Costs and benefits of intraoperative MR-guided brain tumor resection. Acta Neurochir. 2002; 85: 137-142.
107. Hall WA, Liu H, Truwit CL. MR spectroscopy-guided biopsy of intracranial neoplasms. Techniques in Neurosurgery. 2002; 7: 291-298.
108. Tummala RP, Chu RM, Liu H, Truwit CL, Hall WA. High-field functional capabilities for magnetic resonance imaging-guided brain tumor resection. Techniques in Neurosurgery. 2002; 7: 319-325.
109. Liu H, Hall WA, Truwit CL. Remotely-controlled approach to stereotactic neurobiopsy. Computer Aided Surgery. 2002; 7: 237-247.
110. Hall WA, Rustamzadeh E, Asher AL. Convection-enhanced delivery in clinical trials. Neurosurgical Focus. 2003; 14(2).
111. Hall WA, Liu H, Truwit CL. Intraoperative MR-guided instillation of phosphorus-32 for cystic craniopharyngiomas. Case report. Tech in Can Res & Treat. 2003; 2: 19-23.
112. Hartkens T, Hill DLG, Hall WA, et al. Measuring brain deformation during neurosurgery. IEEE Transactions on Medical Imaging. 2003; 22: 82-92.
113. Tummala RP, Chu RM, Liu H, Truwit CL, Hall WA. Application of diffusion tensor imaging to magnetic resonance-guided brain tumor resection. Pediatric Neurosurgery. 2003; 39: 39-43.
114. Kim KU, Ni HT, Cho KH, Spellman SR, Low WC, Hall WA. Changes in expression of transferrin, insulin-like growth factor-1, and interleukin-4 receptors after irradiation of primary malignant brain tumor cell lines. Radiation Research. 2003; 160: 224-231.
115. Maron BJ, Poliac LC, Hall WA, Ashare AB. Sudden death due to neck blows among amateur hockey players. JAMA. 2003; 290: 599-601.
116. Rustamzadeh E, Low WC, Vallera DA, Hall WA. Immunotoxin therapy for CNS tumors. J Neurooncology. 2003; 64: 101-116.
117. Rustamzadeh E, Li C, Doumbia S, Hall WA, Vallera DA. Targeting the overexpressed urokinase-type plasminogen activator receptor on glioblastoma multiforme. J Neurooncology. 2003; 65: 63-75.
118. Weber F, Asher A, Hall WA, et al. Safety, tolerability, and tumor response of IL4-toxin (NBI-3001) in patients with recurrent malignant gliomas. J Neurooncology. 2003; 64: 125-137.
119. Lo SS, Hall WA, Cho KH, Orner J, Lee CK, Dusenbery KE. Radiation dose response for supratentorial low-grade glioma-institutional experience and literature review. J Neurol Sci. 2003; 15: 43-48.
120. Chu RM, Tummala RP, Hall WA. Intraoperative magnetic resonance imaging-guided neurosurgery. Neurosurgery Quarterly. 2003; 13: 234-250.
121. Weber FW, Floeth F, Hall W, et al. Local convection enhanced delivery of IL-4-Pseudomonas exotoxin (NBI-3001) for treatment of patients with recurrent malignant glioma. Acta Neurochir. 2003; 88: 93-103.
122. Hall WA. Extending survival in gliomas: surgical resection or immunotherapy? Surg Neurol. 2004; 61: 145-148.
123. Cho KH, Hall WA, Lo SS, Dusenbery KE. Stereotactic radiosurgery versus fractionated stereotactic radiotherapy boost for patients with glioblastoma multiforme. Tech in Can Res & Treat. 2004; 3: 41-49.
124. Wu A-H, Hall WA, Low WC. Identification of HLA a0201 glioblastoma multiforme cell lines for immunotherapy by PCR-SP and DNA sequencing. J Neurooncol. 2004; 66: 1-8.
125. Jean WC, Spellman SR, Hall WA, et al. Effects of combined granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin 12-based immunotherapy against intracranial glioma in rat. J Neurooncol. 2004; 66: 39-49. doi: 10.1023/B:NEON.0000013477.94568.0f
126. Todhunter DA, Hall WA, Rustamzadeh E, Shu Y, Doumbia SO, Vallera DA. A bispecific immunotoxin (DTAT13) targeting human IL-13 receptor (IL-13R) and urokinase-type plasminogen activator receptor (uPAR) in a mouse xenograft model. Protein Engineering. 2004; 17: 157-164.
127. Anderson C, Graupman P, Sweeny M, Hall WA, Lam CL. Pediatric intracranial complications of central venous catheter placement-case reports. Pediatric Neurosurgery. 2004; 40: 28-31.
128. Djalilian HR, Lessan K, Hall WA, et al. A new immune competent animal model of mucosally derived squamous cell carcinoma. Otolaryngology, Head and Neck Surgery. 2004; 131: 781-783.
129. Gerbi BJ, Higgins PD, Cho KW, Hall WA, Maxwell RE, Orner J. Linac-based stereotactic radiosurgery for treatment of trigeminal neuralgia. Journal of Applied Clinical Medical Physics. 2004; 5: 80-90.
130. Tummala RP, Chu RM, Hall WA. Subdural empyema in children. Neurosurgery Quarterly. 2004; 14: 257-265.
131. Kubicek GJ, Hall WA, Orner JB, Gerbi BJ, Dusenbery KE. Long-term follow-up of trigeminal neuralgia treatment using a linear accelerator. J Functional Stereotactic Neurosurg. 2004; 82: 244-249.
132. Hall WA, Truwit CL. 1.5 Tesla: Spectroscopy supported brain biopsy. Neurosurg Clin N Am. 2005; 16: 165-172.
133. Doolittle ND, Abrey LE, Hall WA, et al. New frontiers in translational research in neuro-oncology and the blood-brain barrier: Report of the tenth annual blood-brain barrier disruption consortium meeting. Clin Cancer Res. 2005; 11: 421-428.
134. Hall WA, Liu H, Truwit CL. Functional MRI-guided resection of low grade gliomas. Surg Neurol. 2005; 64: 20-27.
135. Hall WA, Truwit CL. Intraoperative MR imaging. Magn Reson Imaging Clin N Am. 2005; 13: 533-543.
136. Wu A-H, Xiao J, Hall WA, et al. Identification of EGFRvIII-derived CTL epitopes restricted by HLA A0201 for dendritic cell based immunotherapy of gliomas. J Neurooncol. 2006; 76: 23-30.
137. Truwit CL, Hall WA. Intraoperative magnetic resonance imaging-guided neurosurgery at 3-T. Neurosurgery. 2006; 58(2): 338-346.
138. Hall WA, Sherr G. Convection-enhanced delivery of targeted toxins for malignant glioma. Expert Opin Drug Deliv. 2006; 3: 371-377.
139. Rustamzadeh E, Hall WA, Todhunter D, et al. Intracranial therapy of glioblastoma with the fusion protein DT390IL13 in immunodeficient mice. Int J Cancer. 2006; 118: 2594-2601.
140. Hall WA, Sherr G. Convection-enhanced delivery: Targeted toxin treatment of malignant glioma. Neurosurg Focus. 2006; 20(4): E10.
141. Hall WA, Vallera DA. Anti-angiogenic targeted toxins against glioblastoma. Neurosurg Focus. 2006; 20 (4): E23.
142. Hall WA, Doolittle N, Daman M, et al. Osmotic blood-brain barrier disruption chemotherapy for diffuse pontine gliomas. J Neurooncol. 2006; 77:279-284.
143. Turner SG, Hall WA. Programmable shunt-related suicide attempt. Case report. Acta Neurochir (Wien). 2006; 148: 1307-1310.
144. Rustamzadeh E, Hall W, Todhunter D, et al. Intracranial therapy of glioblastoma with the fusion protein DTAT in immunodeficient mice. Int J Cancer. 2007; 120: 411-419.
145. Rustamzadeh E, Hall WA, Todhunter D, Low WC, Elson M, Vallera DA. Immunotoxin pharmokinetics: A comparison of the anti-glioblastoma bi-specific fusion protein (DTAT13) to DTAT and DTIL13. J Neurooncol. 2006; 77: 257-266.
146. Hall WA, Galicich W, Bergman T, Truwit CL. 3-Tesla Intraoperative MR Imaging for Neurosurgery. J Neurooncol. 2006; 77: 297-303.
147. Hall WA, Truwit CL. 3-tesla functional magnetic resonance imaging-guided tumor resection. Int J CARS. 2007; 1: 223-230.
148. Doolittle ND, Peereboom DM, Hall WA, et al. Delivery of chemotherapy and antibodies across the blood-brain barrier and the role of chemoprotection in primary and metastatic brain tumors: report of the eleventh annual blood-brain barrier consortium meeting. J Neurooncol. 2007; 81: 81-91.
149. McClelland S III, Higgins PD, Gerbi BJ, Orner JB, Hall WA. Fractionated stereotactic radiotherapy for pituitary adenomas following microsurgical resection: safety and efficacy. Technol Cancer Res Treat. 2007; 6: 177-180.
150. Muldoon LL, Soussain C, Hall W, et al. Chemotherapy delivery issues in central nervous system malignancy: a reality check. J Clin Oncol. 2007; 25: 2595-2305.
151. McClelland S III, Hall WA. Postoperative central nervous system infection: incidence and associated factors in 2,111 neurosurgery cases. Clin Inf Dis. 2007; 45: 55-59.
152. Djalilian HR, Caicedo E, Hall WA, et al. Efficacy of an osmotic pump delivered, GM-CSF-based tumor vaccine in the treatment of upper aerodigestive squamous cell carcinoma in rats. Cancer Immunol Immunother. 2007; 56: 1207-1214.
153. McClelland S III, Higgins PD, Dusenbery K, Hall WA. Fractionated stereotactic radiotherapy for facial nerve neuroma. J Functional Stereotactic Neurosurg. 2007; 85: 299-302.
154. Oh S, Odland R, Hall WA, et al. Hollow fiber catheter improves the distribution of small molecules and viral vectors in the mammalian brain. J Neurosurg. 2007; 107: 568-577.
155. McClelland S III, Gerbi BJ, Cho KH, Hall WA. The treatment of a large acoustic tumor with fractionated stereotactic radiotherapy. J Robotic Surg. 2007; 1: 227-230.
156. McClelland S III, Higgins PD, Gerbi BJ, Orner JB, Hall WA. Safety and efficacy of fractionated stereotactic radiotherapy for acoustic neuromas. J Neurooncol. 2008; 86: 191-194.
157. SantaCruz K, Brace J, Hall WA. A case of cranial fasciitis originating within the diploic space of an adult. Neurosurgery. 2007; 61: 1338.
158. Wu A, Xiao J, Chen W, Hall WA, Low WC, Ohlfest JR. Expression of MHC I and NK ligands on human CD133+ brain tumor stem cells: possible targets of immunotherapy. J Neurooncol. 2007; 83: 121-131.
159. Hall WA, Truwit CL. Intraoperative MR-guided neurosurgery. J Magn Reson Imaging. 2008; 27: 368-375.
160. Wu A, Ericson K, Oh S, Hall WA, et al. Persistence of CD133+ cells in human and mouse glioma cell lines: detailed characterization of GL261 glioma cells with cancer stem cell-like properties. Stem Cells and Development. 2008; 17: 173-184. doi: 10.1089/scd.2007.0133
161. Hall WA, Truwit CL. The surgical management of infections involving the cerebrum. Neurosurgery. 2008; 62: SHC519-531. doi: 10.1227/01.neu.0000316255.36726.5b
162. Martin AJ, Hall WA, Roark C, Starr PA, Larson PS, Truwit CL. Minimally invasive precision brain access using prospective stereotaxy and a trajectory guide. J Magn Reson Imaging. 2008; 27: 737-743. doi: 10.1002/jmri.21318
163. Hall WA, Kim P, Truwit CL. Functional magnetic resonance imaging-guided brain tumor resection. Top Magn Reson Imaging. 2009; 19: 205-212. doi: 10.1097/RMR.0b013e3181934a09
164. Hall WA. Magnetic resonance imaging in neurointervention. Top Magn Reson Imaging. 2009; 19: 177. doi: 10.1097/RMR.0b013e31819699b1
165. Hall WA. Convection-enhanced delivery: neurosurgical issues. Curr Drug Target. 2009; 10: 126-130.
166. Kim PD, Truwit CL, Hall WA. Three-tesla high field applications. Neurosurg Clin N Amer. 2009; 20: 173-178. doi: 10.1016/j.nec.2009.04.009
167. Oh S, Ohlfest JR, Hall WA, et al. Intracranial elimination of human glioblastoma brain tumors in nude rats using the bispecific ligand-directed toxin, DTEGF13 and convection enhanced delivery. J Neurooncol. 2009; 95: 331-342. doi: 10.1007/s11060-009-9932-2
168. Li YM, Hall WA. Targeted toxins in brain tumor therapy. Toxins. 2010; 2: 2645-2662. doi: 10.3390/toxins2112645
169. Hall WA, Truwit CL. Intraoperative magnetic resonance imaging. Curr Med Image Rev . 2010; 6: 266-272.
170. Hall WA, Truwit CL. Intraoperative magnetic resonance imaging. Acta Neurochir. 2011; 109: 119-129. doi: 10.1007/978-3-211-99651-5_19
171. Abdulhamid MM, Li YM, Hall WA. Spontaneous acute subdural hematomas as the initial manifestation of chronic myeloid leukemia. case report. J Neurooncol. 2011; 101: 513-516. doi: 10.1007/s11060-010-0278-6
172. Hall WA. Brain abscess: still a surgical entity. World Neurosurg. 2011; 75: 616-617.
173. Li YM, Hall WA. Cell surface receptors on malignant glioma. Neurosurgery. 2011; 69: 980-994. doi: 10.1227/NEU.0b013e318220a672
174. Hall WA. To clip or not to clip, that is the question?. World Neurosurgery. 2012; 77: 291-292.
175. Huang J, Li YM, Massague J, Sicheneder A, Vallera DA, Hall WA. Intracerebral infusion of the bispecific targeted toxin DTATEGF in a mouse xenograft model of a human metastatic non-small cell lung cancer. J Neurooncol. 2012; 109: 229-238. doi: 10.1007/s11060-012-0904-6
176. Hall WA. Free-living amoebas: is it safe to go in the water? . World Neurosurgery. 2012; 78: 610-611.
177. Kim PD, Hall WA. Use of positron emission tomography scanning to evaluate pseudoresponse Trans Pediatrics. 2013; 2: 57-58. doi: 10.3978/j.issn.2224-4336.2013.04.07
178. Li YM, Vallera DA, Hall WA. Diphtheria toxin-based targeted toxin therapy for brain tumors. J Neurooncol. 2013; 114: 155-164. doi: 10.1007/s11060-013-1157-8
179. Li YM, Blaskiewicz DJ, Hall WA. Shunt related intracranial abscess caused by Staphylococcus lugdunensis in a hydranencephalic patient. World Neurosurgery. 2013; 80: e387-389.
180. Hall WA. Spinal parasites. World Neurosurgery. 2013; S1878.
181. Hall WA. Improving outcomes in cerebral aspergillosis. World Neurosurgery. 2014; 82: e139-140.
182. Hall WA. Cranioplasty infections – adding insult to injury. World Neurosurgery. 2014; 82: e435-437. doi: 10.1016/j.wneu.2013.03.005
183. Hall WA, Li YM, Vallera DA. Diphtheria-based immunotoxins that target glioblastoma multiforme. Toxin Rev. 2014; 33: 119-124.